225 related articles for article (PubMed ID: 31151932)
21. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
22. Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
Shen J; Zhai J; Wu X; Xie G; Shen L
J Cell Mol Med; 2020 Jun; 24(12):6750-6761. PubMed ID: 32363730
[TBL] [Abstract][Full Text] [Related]
23. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
[TBL] [Abstract][Full Text] [Related]
24. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.
Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC
Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.
Kanda M; Suh YS; Park DJ; Tanaka C; Ahn SH; Kong SH; Lee HJ; Kobayashi D; Fujiwara M; Shimada H; Cho B; Murotani K; Kim HH; Yang HK; Kodera Y
Gastric Cancer; 2020 Mar; 23(2):203-211. PubMed ID: 31377880
[TBL] [Abstract][Full Text] [Related]
26. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
27. CircRNA
Li R; Tian X; Jiang J; Qian H; Shen H; Xu W
Biomarkers; 2023 Dec; 28(5):448-457. PubMed ID: 37128800
[TBL] [Abstract][Full Text] [Related]
28. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
32. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
34. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls.
Dong L; Qi P; Xu MD; Ni SJ; Huang D; Xu QH; Weng WW; Tan C; Sheng WQ; Zhou XY; Du X
Int J Cancer; 2015 Sep; 137(5):1128-35. PubMed ID: 25694351
[TBL] [Abstract][Full Text] [Related]
35. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
37. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
38. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
39. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
